Skip to NavigationSkip to content

Pharmafile - Research and Development News

American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to cure mice with HIV.
Roche has unveiled new Phase 3 data indicating that Xofluza was well-tolerated and of comparable efficacy to its other therapy Tamiflu in the...
The Department of Health and Human Services (HHS) has been awarded a new patent on drugs that prevent HIV.
Democrat Presidential candidate Elizabeth Warren has criticised Scott Gottlieb for joining Pfizer.
Biogen has introduced new data on the efficacy of Spinraza in the treatment of pre-symptomatic infants in spinal muscular atrophy (SMA), bolstering...
The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations...
Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in...
The UK remains split right down the middle as the Brexit crisis rolls on and on, and while we have been side-tracked from one political wedge to...
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news was undoubtedly the announcement of a $63...
A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in developed nations in...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches